Delayed Coronary Obstruction After TAVR: A Complication We Had Not Considered

Delayed coronary obstruction (after TAVR, outside the cath lab) is a rare complication with high mortality rates, not unlike acute obstruction. Cardiologists should be expectant and, upon the slightest suspicion of this complication, patients should be brought back to the cath lab for a coronary angiography.

Transcatheter Valve Replacement in the Bicuspid Valve Is Increasingly Performed, but Challenges RemainOcclusion immediately after implant release has been well-studied and described (risk factors, prevention techniques, more akin devices, etc.), but we ignored that this event can take place even months after the procedure.

 

Data for this work were retrospectively collected from an international multicenter registry between 2005 and 2016.

 

During the study period, 38 delayed coronary obstructions (incidence 0.22%) were observed after TAVR from a total of 17,092 patients. Occlusions were more common after valve-in-valve procedures (0.89% vs. 0.18%; p < 0.001) and in cases in which self-expandable valves were used during the index procedure (0.36% vs. 0.11% for balloon-expandable; p < 0.01).


Read also: Permanent Pacemaker: still TAVR’s Aquila’s Heel.


Delayed occlusion was most frequent within 24 hours from the procedure (47.4%; n = 18); 6 (15.8%) cases occurred between 24 hours and 7 days, and the remaining 14 (36.8%) occurred within 60 days.

 

The most frequent presentation was cardiac arrest (31.6%), followed by ST-segment elevation myocardial infarction (23.7%; n = 9). The left coronary artery was the culprit vessel in most cases (92.1%).

 

Stent implantation in this registry was successful in about 70% of all patients, thus indicating that angioplasty should be attempted whenever possible.


Read also: Which Low-Flow, Low-Gradient Patients Benefit from Valve Replacement?


In-hospital mortality reached 50% and was higher among patients who experienced the event within 7 days from the index procedure (62.5% vs. 28.6%; p = 0.09).

 

Conclusion

Delayed coronary occlusion following TAVR is a rare phenomenon with an extremely high mortality rate. Angioplasty should be attempted whenever possible, since stent implantation was successful in about 70% of all cases.

 

Original title: Delayed Coronary Obstruction After Transcatheter Aortic Valve Replacement.

Reference: Richard J. Jabbour et al. J Am Coll Cardiol 2018;71:1513-24.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites...

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with severe symptomatic aortic stenosis. Primary transfemoral access...

Asymptomatic Aortic Stenosis: A Complex Decision

Asymptomatic severe aortic stenosis continues to pose a significant challenge when it comes to clinical decision-making, often due to the difficulty in identifying symptoms....

TAVI and Aortic Regurgitation: Are All Valves the Same?

Aortic regurgitation (AR) accounts for 0.5- 2.2% of all cases of valve disease in individuals over 65 years old. According to current guidelines, surgery is...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

TRILUMINATE: Liver and Kidney Failure in Tricuspid Valve Edge-to-Edge Repair

Severe tricuspid regurgitation (TR) will affect roughly 3% of the 65+ population and may lead to liver and kidney failure, which will cause ascites...

Secondary Access in TAVI: Is Transradial Approach our Best Bet?

In some countries, transcatheter aortic valve implantation (TAVI) has become the treatment of choice for patients with severe symptomatic aortic stenosis. Primary transfemoral access...

FAVOR III Europa Sub-Analysis: Coronary Revascularization Deferral Based On QFR vs FFR

When it comes to intermediate coronary lesion revascularization decision making, functional assessment is the recommended. At present, several indices are used, such as fractional...